UK votes to stay in the EMA post-Brex­it

The UK Par­lia­ment on Tues­day vot­ed in fa­vor of con­tin­u­ing the UK’s in­volve­ment with the Eu­ro­pean Med­i­cines Agency (EMA) af­ter the is­land leaves the EU.

The vote (305-301) means Par­lia­ment will make it a ne­go­ti­at­ing ob­jec­tive for the UK gov­ern­ment to seek the UK’s par­tic­i­pa­tion in the Eu­ro­pean med­i­cines reg­u­la­to­ry net­work, ac­cord­ing to the UK BioIn­dus­try As­so­ci­a­tion.

In a joint state­ment on be­half of the phar­ma­ceu­ti­cal in­dus­try in the UK, Mike Thomp­son, chief ex­ec­u­tive of the As­so­ci­a­tion of the British Phar­ma­ceu­ti­cal In­dus­try, and Steve Bates, chief ex­ec­u­tive of the BioIn­dus­try As­so­ci­a­tion, said:

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

SIGN UP LOG IN